prof. Evelyne Meyer (PhD)

CRIG group leader
Evelyne Meyer

Principal investigator - Lab of Biochemistry; Department of Veterinary and Biosciences (UGent)
Full professor (Faculty of Veterinary Medicine, UGent)
Member of the CRIG steering committee (2022-2025)


Research focus

The research mission of the Laboratory of Biochemistry is to contribute to the elucidation of inflammatory processes such as mammary tumor progression and metastasis, using a fully characterised mouse intraductal inoculation model for triple-negative breast cancer. For this purpose several wild type strains as well as genetically modified (e.g. NF-kB reporter) mice are used and 4T1-luc cells are typically inoculated although Py230 cells are an alternative option. This preclinical model is also an elegant screening tool for novel candidate therapeutic molecules such as c-Met inhibitors in comparison to classical chemotherapy (cisplatin). In this context tumor-associated macrophages and neutrophils as key innate immune cells are typically analysed and cytokine profiling as well as IVIS are performed. Complementing this inflammatory profile, chitinase 3-like 1 and lipocalin-2 are evaluated as a novel innate immunity related protein biomarkers for inflammation and metastasis.
The Laboratory of Biochemistry has developed an extensive set of more than 150 standard operation procedures (e.g. for immunohistochemistry, 3-laser flowcytometry, multiplex, cell culture, western blotting, ELISA) to analyze a variety of biological samples such as serum, mammary tumor, lymph node, spleen, lung tissue, and cell culture supernatant obtained from in vivo and in vitro experimental studies.

Research team

  • dr. Jonas Steenbrugge (PhD) - post-doctoral fellow
  • Anna Blockeel - doctoral fellow
  • Robbe Salembier - doctoral fellow
  • Caro De Haes - doctoral fellow
  • Kristel Demeyere - laboratory coordinator

Key publications

  • Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer. Frontiers in Immunology, 2019.
  • Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models. INTERNATIONAL JOURNAL OF CANCER, 2019.
  • Mononuclear but Not Polymorphonuclear Phagocyte Depletion Increases Circulation Times and Improves Mammary Tumor-Homing Efficiency of Donor Bone Marrow-Derived Monocytes. Cancers, 2019.
  • Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018. 
  • Transparent reporting of experimental parameters in assays measuring phenotypic steps in metastasis. CLINICAL & EXPERIMENTAL METASTASIS, 2018.
  • Off-target and tumor-specific accumulation of monocytes, macrophages and myeloid-derived suppressor cells after systemic injection. NEOPLASIA, 2018.
  • Comparison of the adipose and luminal mammary gland compartment as orthotopic inoculation sites in a 4T1-based immunocompetent preclinical model for triple-negative breast cancer. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2016

Contact & links

  • Lab address: Salisburylaan 133, 9820 - Merelbeke
  • Can provide specific platforms or services for other researchers: Immunohistochemical tumor microenvironment characterization (mouse), flow cytometric immunophenotyping, multiplex cytokine profiling 
  • The department of Veterinary and Biosciences 
  • LinkedIn
  • Provaxs 
  • Belgian Society for Advancement of Cytometry (BSAC)
  • prof. Meyer is involved in Animal facility and L2 lab for preclinical cancer research, Laboratory of Biochemistry, Faculty of Veterinary Medicine
  • prof. Meyer is interested to receive invitations for talks or presentations